• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

让腺病毒远离肝脏。

Keeping adenovirus away from the liver.

作者信息

Imperiale Michael J

机构信息

Department of Microbiology and Immunology, University of Michigan Medical School, 1500 E. Medical Center Drive, 6304 Cancer Center, Ann Arbor, MI 48109, USA.

出版信息

Cell Host Microbe. 2008 Mar 13;3(3):119-20. doi: 10.1016/j.chom.2008.02.007.

DOI:10.1016/j.chom.2008.02.007
PMID:18329608
Abstract

While adenovirus holds many advantages as a vector for gene delivery, much of its full potential has been limited by the tendency of the most commonly used vectors to target the liver upon systemic delivery, resulting in unacceptable toxicity. Recently in Cell, Waddington et al. unmasked the virus-host interactions that lead to hepatic transduction. The results point a way toward avoiding this pathway during development of future generations of adenovirus vectors.

摘要

虽然腺病毒作为基因传递载体有许多优点,但其大部分潜力受到常用载体在全身给药时倾向于靶向肝脏的限制,从而导致不可接受的毒性。最近,沃丁顿等人在《细胞》杂志上揭示了导致肝脏转导的病毒与宿主的相互作用。这些结果为在下一代腺病毒载体的开发过程中避免这条途径指明了方向。

相似文献

1
Keeping adenovirus away from the liver.让腺病毒远离肝脏。
Cell Host Microbe. 2008 Mar 13;3(3):119-20. doi: 10.1016/j.chom.2008.02.007.
2
Two key challenges for effective adenovirus-mediated liver gene therapy: innate immune responses and hepatocyte-specific transduction.腺病毒介导的有效肝脏基因治疗面临的两个关键挑战:先天免疫反应和肝细胞特异性转导。
Curr Gene Ther. 2009 Apr;9(2):115-27. doi: 10.2174/156652309787909544.
3
The influence of blood on in vivo adenovirus bio-distribution and transduction.血液对体内腺病毒生物分布和转导的影响。
Mol Ther. 2007 Aug;15(8):1410-6. doi: 10.1038/sj.mt.6300206. Epub 2007 May 15.
4
Molecular basis of the inflammatory response to adenovirus vectors.腺病毒载体炎症反应的分子基础。
Gene Ther. 2003 Jun;10(11):935-40. doi: 10.1038/sj.gt.3302036.
5
Capsid Engineering of Adenovirus Vectors: Overcoming Early Vector-Host Interactions for Therapy.腺病毒载体的衣壳工程:克服早期载体-宿主相互作用的治疗方法。
Hum Gene Ther. 2017 Oct;28(10):820-832. doi: 10.1089/hum.2017.139.
6
A high-capacity, capsid-modified hybrid adenovirus/adeno-associated virus vector for stable transduction of human hematopoietic cells.一种用于人类造血细胞稳定转导的高容量、衣壳修饰的杂交腺病毒/腺相关病毒载体。
J Virol. 2002 Feb;76(3):1135-43. doi: 10.1128/jvi.76.3.1135-1143.2002.
7
Replication-deficient adenovirus induces host topoisomerase I activity: implications for adenovirus-mediated gene expression.复制缺陷型腺病毒诱导宿主拓扑异构酶I活性:对腺病毒介导的基因表达的影响。
Mol Ther. 2007 Apr;15(4):772-81. doi: 10.1038/sj.mt.6300110. Epub 2007 Feb 13.
8
Influence of fiber detargeting on adenovirus-mediated innate and adaptive immune activation.纤维去靶向对腺病毒介导的固有免疫和适应性免疫激活的影响。
J Virol. 2005 Sep;79(18):11627-37. doi: 10.1128/JVI.79.18.11627-11637.2005.
9
Reduction of natural adenovirus tropism to the liver by both ablation of fiber-coxsackievirus and adenovirus receptor interaction and use of replaceable short fiber.通过消融纤维-柯萨奇病毒和腺病毒受体相互作用以及使用可替换的短纤维来降低天然腺病毒对肝脏的嗜性。
J Virol. 2003 Feb;77(4):2512-21. doi: 10.1128/jvi.77.4.2512-2521.2003.
10
Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein.一种含有修饰纤维蛋白的嵌合腺病毒载体对人细胞的选择性靶向作用。
J Virol. 1997 Jun;71(6):4782-90. doi: 10.1128/JVI.71.6.4782-4790.1997.

引用本文的文献

1
Development and application of oncolytic viruses as the nemesis of tumor cells.溶瘤病毒作为肿瘤细胞克星的研发与应用。
Front Microbiol. 2023 Jun 12;14:1188526. doi: 10.3389/fmicb.2023.1188526. eCollection 2023.
2
Gene Therapy Leaves a Vicious Cycle.基因治疗导致恶性循环。
Front Oncol. 2019 Apr 24;9:297. doi: 10.3389/fonc.2019.00297. eCollection 2019.
3
CXCL12 retargeting of an adenovirus vector to cancer cells using a bispecific adapter.使用双特异性衔接子将腺病毒载体的CXCL12重定向至癌细胞。
Oncolytic Virother. 2016 Nov 11;5:99-113. doi: 10.2147/OV.S112107. eCollection 2016.
4
Mutation in fiber of adenovirus serotype 5 gene therapy vector decreases liver tropism.5型腺病毒基因治疗载体纤维蛋白的突变降低了肝脏嗜性。
Int J Clin Exp Med. 2014 Dec 15;7(12):4942-50. eCollection 2014.
5
Substitution of adenovirus serotype 3 hexon onto a serotype 5 oncolytic adenovirus reduces factor X binding, decreases liver tropism, and improves antitumor efficacy.将腺病毒血清型 3 六邻体替换到血清型 5 溶瘤腺病毒上可减少因子 X 的结合,降低肝脏趋向性,并提高抗肿瘤疗效。
Mol Cancer Ther. 2010 Sep;9(9):2536-44. doi: 10.1158/1535-7163.MCT-10-0332. Epub 2010 Aug 24.